The application of genetic engineering methods to mice has greatly expanded the ability to study the molecular basis of physiology and behavior in health and disease. Targeted disruptions or insertions of single genes are unique in that they promise to elucidate the precise role of many endogenous factors important during ontogeny and adult life in a manner which is relatively precise and free of the side eects encountered with many pharmacologic probes. Though the deletion or insertion of a gene may be a relativelỳ clean' process, interpretation of the resulting phenotype may not be straightforward, since most behaviors and physiologic processes are controlled by more than a single gene. In fact, the knocking out or insertion of a single gene may result in no phenotypic change. This may be the case, in particular, if there exist gene redundancy mechanisms whose presence may prevent abnormal phenotypes from becoming unmasked. Conversely, single genes are often essential in a number of dierent behaviors and physiologic processes. Hence, ablation of an individual gene may prove so drastic as to be lethal, or so widespread as to create an amalgam of phenotypes whose interpretation becomes confounded by the interactions of the various new physiologic changes or behaviors.
A legacy of the conventional knock-out methodology is the fact that many genetic mutant mice are a hybrid of two strains. Aberrant traits linked to unusual alleles in the genetic background of the progenitor strains may confound interpretation of the behavioral phenotypes of the ospring. Further, dierent breeding strategies will result in mutants with dierent genetic loading from the maternal and paternal genomes. An exceptional case in point can be found in mice lacking the gene for transforming growth factor b1 (Tgfb1), a protein important in growth, dierentiation and the functioning of most cells. In these knock-outs, expression of the genetic defect in a C57BL/6, C3H, or 129 mouse strain, or else in a mixed 129 Â CF1, 129 Â C57BL/6, 129 Â C3H, or a 129 Â C57 Â NIH/O1a strain, all produce a wide range of phenotypes with regard to preimplantation development, yolk sac development, bowel and gastric in¯ammation and colon tumor suppression [7] . Strain-related problems have been reviewed by a number of authors, and solutions such as systematically backcrossing the mutation into a single strain, improving statistical sampling by increasing the number of experimental animals, and the use of parental controls in the evaluation of phenotypes are currently in use [6, 14, 15] .
Since genetic mutations in conventional transgenic and knock-out mice exist from the earliest stages of embryogenesis throughout development, phenotypes examined in adulthood will re¯ect their ontogenetic histories. In monoamine oxidase A (MAO-A) de®cient
